Cite
MLA Citation
Heidi D. Finnes et al.. “Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice.” Leukemia & lymphoma, vol. 58, no. 6, 2017, pp. 1376–1383. http://access.bl.uk/ark:/81055/vdc_100042870929.0x00005b